Pages that link to "Q34595921"
The following pages link to HIV entry inhibitors and their potential in HIV therapy (Q34595921):
Displaying 30 items.
- A kinome RNAi screen identified AMPK as promoting poxvirus entry through the control of actin dynamics (Q27314508) (← links)
- Nanotechnology and HIV: potential applications for treatment and prevention (Q30393980) (← links)
- Identification of a new region of SARS-CoV S protein critical for viral entry (Q33512190) (← links)
- RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice (Q33730699) (← links)
- Novel approaches in anti-arenaviral drug development (Q33779739) (← links)
- Structure-based identification and neutralization mechanism of tyrosine sulfate mimetics that inhibit HIV-1 entry (Q33972838) (← links)
- Anti-AIDS agents 90. novel C-28 modified bevirimat analogues as potent HIV maturation inhibitors. (Q36340098) (← links)
- Short Communication: Inhibition of DC-SIGN-Mediated HIV-1 Infection by Complementary Actions of Dendritic Cell Receptor Antagonists and Env-Targeting Virus Inactivators. (Q36406899) (← links)
- Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents (Q37173329) (← links)
- Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents (Q37330178) (← links)
- The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research. (Q37379470) (← links)
- Membrane topology of gp41 and amyloid precursor protein: interfering transmembrane interactions as potential targets for HIV and Alzheimer treatment. (Q37556743) (← links)
- IFN-λ Inhibits Drug-Resistant HIV Infection of Macrophages (Q37681541) (← links)
- Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach (Q37699332) (← links)
- HIV microbicides: state-of-the-art and new perspectives on the development of entry inhibitors (Q37855900) (← links)
- Improving potencies and properties of CD4 down-modulating CADA analogs (Q37999087) (← links)
- Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating Potencies. (Q38786622) (← links)
- Binding Site Geometry and Subdomain Valency Control Effects of Neutralizing Lectins on HIV-1 Viral Particles. (Q40565487) (← links)
- Synthesis and Biological Evaluation of Macrocyclized Betulin Derivatives as a Novel Class of Anti-HIV-1 Maturation Inhibitors (Q42021180) (← links)
- Diverse reactivity in microwave-promoted catalyst-free coupling of substituted anilines with ethyl trifluoropyruvate and biological evaluation (Q42283202) (← links)
- Removing human immunodeficiency virus (HIV) from human blood using immobilized heparin (Q45360762) (← links)
- Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers (Q47800411) (← links)
- The safety, tolerability, and pharmacokinetic profile of GSK2838232, a novel 2nd generation HIV maturation inhibitor, as assessed in healthy subjects. (Q55416649) (← links)
- Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor (Q59350387) (← links)
- The Effects of Statistical Multiplicity of Infection on Virus Quantification and Infectivity Assays (Q59358421) (← links)
- Flavonol 7--Glucoside Herbacitrin Inhibits HIV-1 Replication through Simultaneous Integrase and Reverse Transcriptase Inhibition (Q64248875) (← links)
- An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing (Q89759514) (← links)
- Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers (Q89834871) (← links)
- A Phase 1 Study to Assess the Relative Bioavailability, Food Effect, and Safety of a Tablet Formulation of GSK2838232, a Novel HIV Maturation Inhibitor in Healthy Participants After Single and Repeated Doses (Q96587009) (← links)
- Small molecules block the interaction between porcine reproductive and respiratory syndrome virus and CD163 receptor and the infection of pig cells (Q98163710) (← links)